Cargando…

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age

PURPOSE: To evaluate a model for calculating the risk of AF and its relationship with the incidence of ischemic stroke and prevalence of cognitive decline. MATERIALS AND METHODS: It was a multicenter, observational, retrospective, community-based study of a cohort of general population ≥6ct 35 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Clua-Espuny, Jose-Luis, Muria-Subirats, Eulalia, Ballesta-Ors, Juan, Lorman-Carbo, Blanca, Clua-Queralt, Josep, Palà, Elena, Lechuga-Duran, Iñigo, Gentille-Lorente, Delicia, Bustamante, Alejandro, Muñoz, Miguel Ángel, Montaner, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605602/
https://www.ncbi.nlm.nih.gov/pubmed/33149596
http://dx.doi.org/10.2147/VHRM.S276477
_version_ 1783604335296380928
author Clua-Espuny, Jose-Luis
Muria-Subirats, Eulalia
Ballesta-Ors, Juan
Lorman-Carbo, Blanca
Clua-Queralt, Josep
Palà, Elena
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Bustamante, Alejandro
Muñoz, Miguel Ángel
Montaner, Joan
author_facet Clua-Espuny, Jose-Luis
Muria-Subirats, Eulalia
Ballesta-Ors, Juan
Lorman-Carbo, Blanca
Clua-Queralt, Josep
Palà, Elena
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Bustamante, Alejandro
Muñoz, Miguel Ángel
Montaner, Joan
author_sort Clua-Espuny, Jose-Luis
collection PubMed
description PURPOSE: To evaluate a model for calculating the risk of AF and its relationship with the incidence of ischemic stroke and prevalence of cognitive decline. MATERIALS AND METHODS: It was a multicenter, observational, retrospective, community-based study of a cohort of general population ≥6ct 35 years, between 01/01/2016 and 31/12/2018. Setting: Primary Care. Participants: 46,706 people ≥65 years with an active medical history in any of the primary care teams of the territory, information accessible through shared history and without previous known AF. Interventions: The model to stratify the risk of AF (PI) has been previously published and included the variables sex, age, mean heart rate, mean weight and CHA2DS2VASc score. Main measurements: For each risk group, the incidence density/1000 person/years of AF and stroke, number of cases required to detect a new AF, the prevalence of cognitive decline, Kendall correlation, and ROC curve were calculated. RESULTS: The prognostic index was obtained in 37,731 cases (80.8%) from lowest (Q1) to highest risk (Q4). A total of 1244 new AFs and 234 stroke episodes were diagnosed. Q3-4 included 53.8% of all AF and 69.5% of strokes in men; 84.2% of all AF and 85.4% of strokes in women; and 77.4% of cases of cognitive impairment. There was a significant linear correlation between the risk-AF score and the Rankin score (p < 0.001), the Pfeiffer score (p < 0.001), but not NIHSS score (p 0.150). The overall NNS was 1/19. CONCLUSION: Risk stratification allows identifying high-risk individuals in whom to intervene on modifiable risk factors, prioritizing the diagnosis of AF and investigating cognitive status.
format Online
Article
Text
id pubmed-7605602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76056022020-11-03 Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age Clua-Espuny, Jose-Luis Muria-Subirats, Eulalia Ballesta-Ors, Juan Lorman-Carbo, Blanca Clua-Queralt, Josep Palà, Elena Lechuga-Duran, Iñigo Gentille-Lorente, Delicia Bustamante, Alejandro Muñoz, Miguel Ángel Montaner, Joan Vasc Health Risk Manag Original Research PURPOSE: To evaluate a model for calculating the risk of AF and its relationship with the incidence of ischemic stroke and prevalence of cognitive decline. MATERIALS AND METHODS: It was a multicenter, observational, retrospective, community-based study of a cohort of general population ≥6ct 35 years, between 01/01/2016 and 31/12/2018. Setting: Primary Care. Participants: 46,706 people ≥65 years with an active medical history in any of the primary care teams of the territory, information accessible through shared history and without previous known AF. Interventions: The model to stratify the risk of AF (PI) has been previously published and included the variables sex, age, mean heart rate, mean weight and CHA2DS2VASc score. Main measurements: For each risk group, the incidence density/1000 person/years of AF and stroke, number of cases required to detect a new AF, the prevalence of cognitive decline, Kendall correlation, and ROC curve were calculated. RESULTS: The prognostic index was obtained in 37,731 cases (80.8%) from lowest (Q1) to highest risk (Q4). A total of 1244 new AFs and 234 stroke episodes were diagnosed. Q3-4 included 53.8% of all AF and 69.5% of strokes in men; 84.2% of all AF and 85.4% of strokes in women; and 77.4% of cases of cognitive impairment. There was a significant linear correlation between the risk-AF score and the Rankin score (p < 0.001), the Pfeiffer score (p < 0.001), but not NIHSS score (p 0.150). The overall NNS was 1/19. CONCLUSION: Risk stratification allows identifying high-risk individuals in whom to intervene on modifiable risk factors, prioritizing the diagnosis of AF and investigating cognitive status. Dove 2020-10-28 /pmc/articles/PMC7605602/ /pubmed/33149596 http://dx.doi.org/10.2147/VHRM.S276477 Text en © 2020 Clua-Espuny et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Clua-Espuny, Jose-Luis
Muria-Subirats, Eulalia
Ballesta-Ors, Juan
Lorman-Carbo, Blanca
Clua-Queralt, Josep
Palà, Elena
Lechuga-Duran, Iñigo
Gentille-Lorente, Delicia
Bustamante, Alejandro
Muñoz, Miguel Ángel
Montaner, Joan
Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title_full Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title_fullStr Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title_full_unstemmed Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title_short Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
title_sort risk of atrial fibrillation, ischemic stroke and cognitive impairment: study of a population cohort ≥65 years of age
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605602/
https://www.ncbi.nlm.nih.gov/pubmed/33149596
http://dx.doi.org/10.2147/VHRM.S276477
work_keys_str_mv AT cluaespunyjoseluis riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT muriasubiratseulalia riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT ballestaorsjuan riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT lormancarboblanca riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT cluaqueraltjosep riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT palaelena riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT lechugaduraninigo riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT gentillelorentedelicia riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT bustamantealejandro riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT munozmiguelangel riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT montanerjoan riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage
AT riskofatrialfibrillationischemicstrokeandcognitiveimpairmentstudyofapopulationcohort65yearsofage